Trident Lifeline Past Earnings Performance
Past criteria checks 0/6
Trident Lifeline has been growing earnings at an average annual rate of 5.5%, while the Pharmaceuticals industry saw earnings growing at 14.2% annually. Revenues have been growing at an average rate of 40.8% per year. Trident Lifeline's return on equity is 11%, and it has net margins of 14.2%.
Key information
5.5%
Earnings growth rate
-17.0%
EPS growth rate
| Pharmaceuticals Industry Growth | 17.5% |
| Revenue growth rate | 40.8% |
| Return on equity | 11.0% |
| Net Margin | 14.2% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Trident Lifeline makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 446 | 63 | 24 | 0 |
| 31 Dec 23 | 401 | 67 | 22 | 0 |
| 30 Sep 23 | 364 | 71 | 19 | 0 |
| 30 Jun 23 | 344 | 67 | 18 | 0 |
| 31 Mar 23 | 317 | 60 | 16 | 0 |
| 31 Dec 22 | 322 | 51 | 15 | 0 |
| 31 Mar 22 | 218 | 39 | 12 | 0 |
Quality Earnings: 543616 has a high level of non-cash earnings.
Growing Profit Margin: 543616's current net profit margins (14.2%) are lower than last year (19%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if 543616's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare 543616's past year earnings growth to its 5-year average.
Earnings vs Industry: 543616 earnings growth over the past year (5.5%) did not outperform the Pharmaceuticals industry 23.1%.
Return on Equity
High ROE: 543616's Return on Equity (11%) is considered low.